Meridian Investment Counsel Inc.
Source: SEC Form 13F · as of Mar 2026Meridian Investment Counsel Inc. holds 14 biotech & pharma companies tracked by BioSniper, totaling $28.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$28.3M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 26,331 | $5.7M |
| JNJJOHNSON & JOHNSON | 23,427 | $5.7M |
| GILDGILEAD SCIENCES, INC. | 32,150 | $4.5M |
| MCKMcKesson Corporation | 3,904 | $3.4M |
| AMGNAMGEN INC | 7,040 | $2.5M |
| NVONovo Nordisk A/S | 62,192 | $2.3M |
| PFEPFIZER INC | 54,925 | $1.5M |
| IBRXImmunityBio, Inc. | 96,433 | $740K |
| MRKMerck & Co., Inc. | 3,793 | $456K |
| GEHCGE HealthCare Technologies Inc. | 5,437 | $387K |
| ABTABBOTT LABORATORIES | 3,621 | $372K |
| ZBHZimmer Biomet Holdings Inc. | 2,725 | $246K |
| CAHCardinal Health Inc. | 1,142 | $241K |
| BMYBRISTOL MYERS SQUIBB CO | 3,584 | $217K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.